SCHEMBL1615645

SCHEMBL1615645

Cc1noc(C)c1Cn1ccc(NC(=O)CCc2ccccc2)n1

nearest known ligand 0.67

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ TAS2R8 Q9NYW2 7/20 0.67
▸ CACNA1G O43497 10/20 0.53
▸ CACNA1I Q9P0X4 10/20 0.53
▸ CACNA1H O95180 9/20 0.53
▸ RAB9A P51151 1/20 0.47
▸ HCAR2 Q8TDS4 1/20 0.46
▸ CACNA1C Q13936 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614809 0.94 TAS2R8 (0.69) TAS2R8CACNA1GCACNA1ICACNA1HRAB9A
SCHEMBL1615571 0.89 CACNA1G (0.67) TAS2R8CACNA1GCACNA1ICACNA1HCACNA1C
SCHEMBL1615590 0.83 TAS2R8 (0.47) TAS2R8CACNA1GCACNA1ICACNA1H
SCHEMBL1615273 0.83 TAS2R8 (0.65) TAS2R8RAB9A
SCHEMBL1614813 0.82 TAS2R8 (0.68) TAS2R8CACNA1GCACNA1ICACNA1H
SCHEMBL1615825 0.81 TAS2R8 (0.48) TAS2R8
SCHEMBL15114689 0.81 TAS2R8 (0.52) TAS2R8CACNA1GCACNA1ICACNA1H
SCHEMBL1615679 0.80 TAS2R8 (1.00) TAS2R8
SCHEMBL1614797 0.80 TAS2R8 (0.69) TAS2R8CACNA1GCACNA1ICACNA1H
SCHEMBL1615292 0.79 TAS2R8 (0.67) TAS2R8RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9247759-B2 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof SENOMYX, INC. (US) 2016-02-02 — — US disclosed
US-9247759-B2 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof SENOMYX, INC. (US) 2016-02-02 — — US disclosed
US-20130183252-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND METHODS OF MAKING SAME SENOMYX, INC. (US) 2013-07-18 — — US disclosed
US-20130183252-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND METHODS OF MAKING SAME SENOMYX, INC. (US) 2013-07-18 — — US disclosed
US-8445692-B2 Compounds that inhibit (block) bitter taste in composition and use thereof SENOMYX INC. (US) 2013-05-21 — — US disclosed
US-8445692-B2 Compounds that inhibit (block) bitter taste in composition and use thereof SENOMYX INC. (US) 2013-05-21 — — US disclosed
US-20120088796-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND USE THEREOF SENOMYX, INC. (US) 2012-04-12 — — US disclosed
US-20120088796-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND USE THEREOF SENOMYX, INC. (US) 2012-04-12 — — US disclosed
US-8148544-B2 Compounds that inhibit (block) bitter taste in composition and methods of making same SENOMYX, INC. (US) 2012-04-03 — — US disclosed
US-8148544-B2 Compounds that inhibit (block) bitter taste in composition and methods of making same SENOMYX, INC. (US) 2012-04-03 — — US disclosed
WO-2011106114-A1 IDENTIFICATION OF HUMAN T2R RECEPTORS AND THE USE THEREOF TO IDENTIFY INHIBITORS (BLOCKERS) OF BITTER TASTE SENOMYX, INC. (US) 2011-09-01 — — WO disclosed
US-20110207937-A1 Compounds that inhibit (block) bitter taste in composition and methods of making same SENOMYX, INC. (US) 2011-08-25 — — US disclosed
US-20110207937-A1 Compounds that inhibit (block) bitter taste in composition and methods of making same SENOMYX, INC. (US) 2011-08-25 — — US disclosed
US-7939671-B2 Compounds that inhibit (block) bitter taste in composition and use thereof SENOMYX, INC. (US) 2011-05-10 — — US disclosed
US-7939671-B2 Compounds that inhibit (block) bitter taste in composition and use thereof SENOMYX, INC. (US) 2011-05-10 — — US disclosed
US-20100254916-A1 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof SENOMYX, INC. (US) 2010-10-07 — — US disclosed
US-20100254916-A1 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof SENOMYX, INC. (US) 2010-10-07 — — US disclosed
US-20090274632-A1 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof SENOMYX, INC. (US) 2009-11-05 — — US disclosed
US-20090274632-A1 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof SENOMYX, INC. (US) 2009-11-05 — — US disclosed
WO-2009025793-A2 HUMAN T2R BITTERNESS RECEPTORS AND USES THEREOF SENOMYX, INC. (US) 2009-02-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207937-A1 Compounds that inhibit (block) bitter taste in composition and methods of making same TAS2R50, TAS2R1, TAS2R5 TAS2R8 19/4885CACNA1G 445/4885CACNA1I 441/4885
US-20090274632-A1 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof TAS2R50, TAS2R1, TAS2R30 TAS2R8 18/4885CACNA1G 715/4885CACNA1I 682/4885
US-20120088796-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND USE THEREOF TAS2R50, TAS2R5, TAS2R1 TAS2R8 20/4885CACNA1G 472/4885CACNA1I 444/4885
US-20100254916-A1 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof TAS2R50, TAS2R1, TAS2R30 TAS2R8 16/4885CACNA1G 702/4885CACNA1I 681/4885
US-20130183252-A1 COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND METHODS OF MAKING SAME TAS2R50, TAS2R1, TAS2R5 TAS2R8 19/4885CACNA1G 445/4885CACNA1I 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback